| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.6M | +178.5% |
| Cost of Revenue | $4.3M | +31.2% |
| Gross Profit | $20.3M | +265.0% |
| R&D Expense | $50.7M | +43.7% |
| SG&A Expense | $41.2M | +27.0% |
| Operating Income | -$100.4M | -30.0% |
| Pre-tax Income | -$355.1M | -146.8% |
| Income Tax | $0 | — |
| Net Income | -$355.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $635.3M | +257.0% |
| Short-term Investments | $249.1M | — |
| Accounts Receivable | $1.6M | +11.8% |
| Inventory | $2.8M | +64.7% |
| Current Assets | $896.2M | +384.3% |
| Total Assets | $915.8M | +358.2% |
| Current Liabilities | $21.1M | -29.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.0M | -68.8% |
| Capital Expenditures | $3.9M | +83.4% |
| Investing Cash Flow | -$251.1M | -7895.4% |
| Financing Cash Flow | $779.1M | +327.0% |
| Free Cash Flow | -$75.8M | -69.5% |
| -146.8% |
| EPS (Basic) | -$1.11 | -48.0% |
| EPS (Diluted) | -$1.11 | -48.0% |
| Long-term Debt |
| $35.8M |
| +18.9% |
| Total Liabilities | $63.6M | -53.7% |
| Stockholders' Equity | $852.2M | +1260.4% |